EUVIMEDEUVIMED entdecken
Crossref

Therapeutic Efficacy and Drug Metabolism of Griseorhodin A Induced by a Co-culture of Actinomycete Strain TMPU-20A002 and Mycobacterium smegmatis in Silkworm Infection Models

Akiho Yagi, Reo Sasaki, Ryuji Uchida

Chemical and Pharmaceutical Bulletin · 2025

DOI: 10.1248/cpb.c25-00389 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical and Pharmaceutical Bulletin, 2025. Verfasst von Akiho Yagi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Natural Product Chemistry, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, 4-4-1 Komatsushima, Aoba-ku,…. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Bombyx, Mycobacterium smegmatis, Actinobacteria. Die Arbeit nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In screening for antibacterial agents from co-cultures of Mycobacterium smegmatis and microbial resources, such as actinomycetes and fungi, the known hydroxyquinone antibiotic griseorhodin A (1) was isolated from a co-culture of actinomycete strain TMPU-20A002 and M. smegmatis. Compound 1 exhibited antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus faecalis (VRE), with minimum inhibitory concentrations of 0.25 and 2.0 μg/mL, respectively. In silkworm infection models with MRSA and VRE, 1 exhibited therapeutic efficacy, with ED50 values of 2.5 and 18 μg/larva·g, respectively. A pharmacokinetic analysis of silkworms revealed an elimination half-life of 4.4 h in the hemolymph, indicating a favorable metabolic profile. This is the first in vivo evaluation of griseorhodin A, including its pharmacological activity and metabolic behavior, and it highlights its potential as a candidate for the development of novel antibacterial agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsBombyxMycobacterium smegmatisActinobacteriaAnimalsMicrobial Sensitivity TestsMethicillin-Resistant Staphylococcus aureusEnterococcus faecalisCoculture TechniquesDisease Models, AnimalDose-Response Relationship, DrugMolecular Structure

Stichwörter der Autor:innen

antibioticco-culturegriseorhodin Anatural productsilkworm infection model

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Division of Natural Product Chemistry, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, 4-4-1 Komatsushima, Aoba-ku, Sendai 981-8558, Japan.

Zitieren

APA

Yagi, A., Sasaki, R., & Uchida, R. (2025). Therapeutic Efficacy and Drug Metabolism of Griseorhodin A Induced by a Co-culture of Actinomycete Strain TMPU-20A002 and Mycobacterium smegmatis in Silkworm Infection Models. Chemical and Pharmaceutical Bulletin. https://doi.org/10.1248/cpb.c25-00389

Vancouver

Yagi A, Sasaki R, Uchida R. Therapeutic Efficacy and Drug Metabolism of Griseorhodin A Induced by a Co-culture of Actinomycete Strain TMPU-20A002 and Mycobacterium smegmatis in Silkworm Infection Models. Chemical and Pharmaceutical Bulletin. 2025. doi:10.1248/cpb.c25-00389

BibTeX
@article{Yagi2025,
  author = {Yagi, Akiho and Sasaki, Reo and Uchida, Ryuji},
  title = {Therapeutic Efficacy and Drug Metabolism of Griseorhodin A Induced by a Co-culture of Actinomycete Strain TMPU-20A002 and Mycobacterium smegmatis in Silkworm Infection Models},
  journal = {Chemical and Pharmaceutical Bulletin},
  year = {2025},
  doi = {10.1248/cpb.c25-00389}
}
Kostenlos starten →